Cantor Fitzgerald Starts Harmony Biosciences Holdings Inc. (HRMY) at Overweight
Tweet
Share
E-mailGet Alerts HRMY Hot Sheet
Price: $38.12 -0.99%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) with a Overweight rating and a price target of $63.00.
For an analyst ratings summary and ratings history on Harmony Biosciences Holdings Inc. click here. For more ratings news on Harmony Biosciences Holdings Inc. click here.
Shares of Harmony Biosciences Holdings Inc. closed at $50.85 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Alliance Global Partners Starts Momentus (MNTS) at Buy
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
